Lion changes management

Lion bioscience (FSE:LIO; LEON) said that, effective immediately, Daniel Keesman, COO and co-CEO, and

Read the full 147 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE